PDEX (STOCKS)
Pro-Dex Inc New
$38.030000
+0.700000 (+1.88%)
Prev close: $37.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Richard Lee van Kirk
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $121.31M
- Employees
- 181
- P/E (TTM)
- 11.18
- P/B (TTM)
- 2.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $72.10M |
| Benefits Costs and Expenses | $56.80M |
| Cost Of Revenue | $51.70M |
| Costs And Expenses | $56.80M |
| Gross Profit | $20.40M |
| Nonoperating Income/Loss | $3.95M |
| Operating Expenses | $9.05M |
| Research and Development | $3.35M |
| Operating Income/Loss | $11.35M |
| Income/Loss From Continuing Operations After Tax | $11.34M |
| Income/Loss From Continuing Operations Before Tax | $15.30M |
| Income Tax Expense/Benefit | $3.96M |
| Net Income/Loss | $2.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$8.82M |
| Net Income/Loss Attributable To Parent | $11.34M |
| Net Income/Loss Available To Common Stockholders, Basic | $11.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.48 |
| Diluted Earnings Per Share | $3.41 |
| Basic Average Shares | 6,507,650 |
| Diluted Average Shares | 6,650,197 |
| Assets | $62.26M |
| Current Assets | $49.19M |
| Inventory | $21.71M |
| Other Current Assets | $27.48M |
| Noncurrent Assets | $13.07M |
| Intangible Assets | $12.00K |
| Other Non-current Assets | $13.06M |
| Liabilities | $20.63M |
| Current Liabilities | $12.20M |
| Accounts Payable | $4.11M |
| Other Current Liabilities | $8.09M |
| Noncurrent Liabilities | $8.42M |
| Equity | $41.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $41.63M |
| Liabilities And Equity | $62.26M |
| Net Cash Flow From Operating Activities | $6.46M |
| Net Cash Flow From Operating Activities, Continuing | $6.46M |
| Net Cash Flow From Investing Activities | $9.51M |
| Net Cash Flow From Investing Activities, Continuing | $9.51M |
| Net Cash Flow From Financing Activities | -$8.08M |
| Net Cash Flow From Financing Activities, Continuing | -$8.08M |
| Net Cash Flow | $7.89M |
| Net Cash Flow, Continuing | $7.89M |
| Comprehensive Income/Loss | $2.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $2.52M |
| Other Comprehensive Income/Loss | $0.00 |